These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Obstructive sleep apnea and drugs as causes of treatment-resistant hypertension]. Waeber B, Feihl F. Rev Med Suisse; 2012 Jan 11; 8(323):28-30. PubMed ID: 22303736 [Abstract] [Full Text] [Related]
26. Masked hypertension: subtypes and target organ damage. Kawano Y, Horio T, Matayoshi T, Kamide K. Clin Exp Hypertens; 2008 Apr 11; 30(3):289-96. PubMed ID: 18425708 [Abstract] [Full Text] [Related]
27. Visit-to-visit blood pressure variability and risk for progression of cardiovascular and renal diseases. Rossignol P, Kessler M, Zannad F. Curr Opin Nephrol Hypertens; 2013 Jan 11; 22(1):59-64. PubMed ID: 23165110 [Abstract] [Full Text] [Related]
28. Prognostic significance of masked and white-coat hypertension in the general population: the Finn-Home Study. Hänninen MR, Niiranen TJ, Puukka PJ, Johansson J, Jula AM. J Hypertens; 2012 Apr 11; 30(4):705-12. PubMed ID: 22278146 [Abstract] [Full Text] [Related]
29. Determinants of masked hypertension in hypertensive patients treated in a primary care setting. Andalib A, Akhtari S, Rigal R, Curnew G, Leclerc JM, Vaillancourt M, Tardif JC. Intern Med J; 2012 Mar 11; 42(3):260-6. PubMed ID: 21118414 [Abstract] [Full Text] [Related]
31. Hypertension in adolescents. Aglony M, Acevedo M, Ambrosio G. Expert Rev Cardiovasc Ther; 2009 Dec 11; 7(12):1595-603. PubMed ID: 19954321 [Abstract] [Full Text] [Related]
32. Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia. Chockalingam A, Abbott D, Bass M, Battista R, Cameron R, de Champlain J, Evans CE, Laidlaw J, Lee BL, Leiter L. CMAJ; 1990 Jun 15; 142(12):1397-409. PubMed ID: 2190686 [No Abstract] [Full Text] [Related]
33. Hypertension diagnosis and prognosis in chronic kidney disease with out-of-office blood pressure monitoring. Agarwal R. Curr Opin Nephrol Hypertens; 2006 May 15; 15(3):309-13. PubMed ID: 16609300 [Abstract] [Full Text] [Related]
34. 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals. International Society for Chronobiology, American Association of Medical Chronobiology and Chronotherapeutics, Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk, Spanish Society of Atherosclerosis, Romanian Society of Internal Medicine, Hermida RC, Smolensky MH, Ayala DE, Portaluppi F. Chronobiol Int; 2013 Apr 15; 30(3):355-410. PubMed ID: 23517220 [Abstract] [Full Text] [Related]
35. Masked Hypertension: Lessons for the Future. Penmatsa KR, Biyani M, Gupta A. Ulster Med J; 2020 Sep 15; 89(2):77-82. PubMed ID: 33093691 [Abstract] [Full Text] [Related]
37. Home blood pressure for the management of hypertension: will it become the new standard of practice? Krakoff LR. Expert Rev Cardiovasc Ther; 2011 Jun 15; 9(6):745-51. PubMed ID: 21714605 [Abstract] [Full Text] [Related]
38. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Hermida RC, Ayala DE, Fernández JR, Mojón A. Chronobiol Int; 2013 Mar 15; 30(1-2):68-86. PubMed ID: 23181592 [Abstract] [Full Text] [Related]
39. Tom Pickering as a clinical scientist: masked hypertension. Eguchi K. Blood Press Monit; 2010 Apr 15; 15(2):85-9. PubMed ID: 20404601 [Abstract] [Full Text] [Related]